Pediatric Clinical Trials: overview
Scientific activity, including participation in large-scale international clinical research, is not only a contribution of each clinic to the struggle for the health of its patients. This is also part of global initiatives that can give a chance to recover to millions of patients around the world. Tel Aviv Medical Clinic, being a full member of the international professional oncology community, conducts clinical research on its basis in partnership with leading global companies developing new methods, technologies and drugs for the treatment of cancer.
From the outset, Tel Aviv Medical Clinic has laid the foundation for continuous improvement of its work, which allows participating in clinical research of leading companies, the list of which is constantly expanding, which simplifies the access of clinic patients to innovative medical achievements.
How to become a participant in clinical trials
For patients, participation in clinical research is an opportunity to receive free treatment with the latest drugs. However, the rules for conducting research imply clear compliance with the criteria of each of them. The specific phase of the disease, the history of the treatment received earlier, its effectiveness, comorbidities, etc. Also, for different phases of clinical research, a certain number of participants are required.
To learn more about the possibility of becoming a participant in clinical research at Tel Aviv Medical Clinic, contact our contact centre by the contacts indicated on our website. In case your data meet the preliminary requirements, Tel Aviv Medical Clinic specialists responsible for clinical research will contact you shortly.
Conduct of the study
Clinical trials typically test a specific intervention, which may be a drug, medical device, or procedure, according to a study protocol developed by the investigator. Children and adolescents are considered adults, and their physiology and chemistry react differently to disease and disease. Thus, pediatric clinical trials are crucial for the development of treatments and treatment for childhood diseases and ailments.
In comparative studies, the new drug is compared to the existing, standard treatment. That is, the control group also receives high-quality, strictly controlled treatment, but in no case a placebo blank. Also, as part of the study protocol, the patient is examined at the expense of a sponsor – a pharmaceutical company.